We have studied the form and fine structure of developing afferent axons in postnatal mouse cerebellum, before and during the formation of synaptic connections. In slices of fresh brain, bundles of axons were injected with horseradish peroxidase (HRP), and individual axons were examined in the light and electron microscopes. At birth, before formation of cortical layers, axons with growing tips are rare in the peduncular tracts but instead ramify throughout the cerebellar anlage. All axons have similar structures; they branch infrequently and terminate in bud-like tips and/or small growth cones. Growth cones contain small and large vesicles in the flank and small vesicles in filopodia.Typical mossy and climbing fiber branching patterns and bouton shapes are recognizable after postnatal day (P) 5, even though fibers are still intermingled in a plexus beneath the newly formed Purkinje cell layer. Climbing fiber-like axon arbors are highly branched and covered with small foliate growing tips that contact Purkinje cells. Mossy fiber-like branches have large irregular expansions that give rise to long filopodia and resemble growth cones seen in uitro. The flanks of these growth cones contact granule cell dendrites and form glomeruli typical of mossy fibers, whereas the filopodia make primitive contacts or are associated with coated vesicles in adjacent profiles. A novel finding is the occurrence during the second postnatal week of many single axons that simultaneously have the morphology and synaptic connections of both climbing and mossy fibers. These "combination" axons have some branches that extend into the granule cell layer and others that enter the Purkinje cell layer, with the shape and synaptic connections of terminals on each branch type corresponding to the respective layer. Climbing fiber-like branches, including those on combination fibers, extend over several adjacent Purkinje cells. Combination fibers are rare in late postnatal or adult stages.These results suggest that long after arrival in the cerebellum, afferent axons have similar elementary forms and overlap in their projections. Mature axonal forms are not exhibited until cellular layers develop. During a limited period of postnatal maturation, some axons have dual morphologies and synaptic relations with appropriate and inappropriate partners. These aspects of cerebellar axonal development, particularly the transient exuberant branching onto two types of target cells, offer a valuable opportunity to examine, in developing cerebellum, the sorting out of afferents and the formation of specific synaptic connections.The means by which axons make synaptic connections of these forms during interactions among different target is a central question in neuronal development. We cur-cell types, as single growth cones transform into synaptic rently understand little about the forms of growing tips arbors. in vivo once axons reach target areas, or the significanceThe behavior of growing axons has been primarily 1 We thank

No abstract

Since Otto Warburg’s first report on the increased uptake of glucose and lactate release by cancer cells, dysregulated metabolism has been acknowledged as a hallmark of cancer that promotes proliferation and metastasis. Over the last century, studies have shown that cancer metabolism is complex, and by-products of glucose and glutamine catabolism induce a cascade of both pro- and antitumorigenic processes. Some vitamins, which have traditionally been praised for preventing and inhibiting the proliferation of cancer cells, have also been proven to cause cancer progression in a dose-dependent manner. Importantly, recent findings have shown that the nervous system is a key player in tumor growth and metastasis via perineural invasion and tumor innervation. However, the link between cancer–nerve crosstalk and tumor metabolism remains unclear. Here, we discuss the roles of relatively underappreciated metabolites in cancer–nerve crosstalk, including lactate, vitamins, and amino acids, and propose the investigation of nutrients in cancer–nerve crosstalk based on their tumorigenicity and neuroregulatory capabilities. Continued research into the metabolic regulation of cancer–nerve crosstalk will provide a more comprehensive understanding of tumor mechanisms and may lead to the identification of potential targets for future cancer therapies.

The rise of tissue-engineered biomaterials has introduced more clinically translatable models of disease, including three-dimensional (3D) decellularized extracellular matrix (dECM) hydrogels. Specifically, decellularized nerve hydrogels have been utilized to model peripheral nerve injuries and disorders in vitro; however, there lacks standardization in decellularization methods. Here, rat sciatic nerves of varying preparations were decellularized using previously established methods: sodium deoxycholate (SD)-based, 3-((3-cholamidopropyl)­dimethylammonio)-1-propanesulfonate (CHAPS)-based, and apoptosis-mediated. These nerves were characterized for cellular debris removal, ECM retention, and low cytotoxicity with cultured Schwann cells. The best preparations of each decellularization method were digested into dECM hydrogels, and rheological characterization, gelation kinetics, and confocal reflectance imaging of collagen fibril assembly were performed. It was determined that the SD-based method with nerve epineurial removal best maintained the overall ECM composition and mechanical properties of physiological peripheral nerves while efficiently stripping the scaffolds of tissue-specific cells and debris. This method was then utilized as a culture platform for quiescent Schwann cells and cancer–nerve crosstalk. Hydrogel-embedded Schwann cells were found to have high viability and act in a more physiologically relevant manner than those cultured in monolayers, and the hydrogel platform allowed for the activation of Schwann cells following treatment with cancer secreted factors. These findings establish a standard for peripheral nerve decellularization for usage as a dECM hydrogel testbed for in vitro peripheral nerve disease modeling and may facilitate the development of treatments for peripheral nerve disease and injury.

No abstract